Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 69948-003

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 69948-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alignscience Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 150mg500s

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 150mg60s

This is a medication called Quetiapine in its extended-release tablet form, which is only available under prescription. Each extended-release tablet contains 172.7 mg of quetiapine fumarate. It is used to treat certain mental/mood disorders. The recommended dosage is one tablet of 150 mg once a day. The medication guide should be given to each patient. Keep the medicine out of the reach of the children. It is advised to store this medication at 25°C with excursions being permitted to 15°t0 30° C. The manufacturer of the medication is AlignScience Pharma Inc., while the tablets are manufactured by Haimen Pharma Inc.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 200mg500s

This is a description of Quetiapine Extended-Release Tablets, USP, with a dosage of 200mg and comes with a medication guide for each patient. The tablets should be swallowed whole and not split, crushed or chewed. They are usually taken once daily, and the accompanying prescribing information must be consulted. It is a warning that the medication should be kept out of children's reach, and they should be stored at 25°C (77°F), with excursions to 15°to 30°C (59° to 86°F). The tablets are manufactured by Haimen Pharma Inc. and distributed by AlignScience Pharma Inc.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 200mg60s

This is a description of a medication called Quetiapine Fumarate, with an NDG number of 69948-003-03, that comes in an extended-release tablet form containing 230.3 mg of the active ingredient. The medication is to be taken once daily and should not be crushed, split or chewed. The prescription document accompanying the medication has specific information on dosage and additional warnings, such as the need to keep out of reach of children. The medication is manufactured in Jiangsu, China, by Haimen Pharma Inc.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 Chemical Structure

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 Figure 1

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 Figure 2

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 Figure 3

The text provided appears to be a graph showing the proportion of patients with relapse over time. The graph indicates that at week 0, 100% of patients experienced relapse. The x-axis (horizontal) is labeled "Time (weeks)" and the y-axis (vertical) is labeled "Proportion of Patients with Relapse (%)". The title of the graph reads "Relapse" with a line below it that appears to read "——= areruvaL" and "PLas LwAL".*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.